News

Amyloid fibrils in the brains of people with a form of frontotemporal lobar degeneration, or FTLD, contain an unexpected protein, say researchers at UCLA.

In addition to memory problems and other cognitive symptoms, most people with Alzheimer’s disease also suffer from mental health issues. It has long been unclear whether these occur because of tissue changes in the brain, or whether they represent psychological reactions to cognitive symptoms. A new study provides insight.

Researchers at the Mayo clinic have reported that neurofilament light is a biomarker for frontotemporal dementia, potentially allowing for quicker diagnoses.

Researchers have successfully designed a new type of artificial vision device that incorporates a novel vertical stacking architecture and allows for greater depth of color recognition and scalability on a micro-level.

The study, led by researchers from UNSW Sydney and published in eLife, found that the pupils of people with aphantasia did not respond when asked to imagine dark and light objects, while those without aphantasia did.

Scientists have developed a novel, high-resolution, personalized model of Deep Brain Stimulation for patients suffering from depression.

Scientists have discovered that hypothalamic neurons in an animal model directly detect variations in gut bacterial activity and adapt appetite and body temperature accordingly.

A new study has found that disulfiram, a drug used to treat chronic alcoholism, can safely reduce anxiety levels in rodents.

Research shows that inhibiting a key signaling pathway in the immune cells of the brain could be a new target to slow the progress of Alzheimer’s disease.

In a work of systematic biology that advances the field, University of Alabama at Birmingham researchers have identified 16 distinct cell populations in a complex area of the midbrain called the ventral tegmental area, or VTA.